Takeda Pharmaceutical
TAK
#470
Rank
S$57.94 B
Marketcap
$18.28
Share price
0.37%
Change (1 day)
-2.54%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2024 (TTM): S$39.48 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is S$39.32 Billion. In 2023 the company made a revenue of S$38.76 Billion a decrease over the revenue in the year 2022 that were of S$39.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$39.48 B1.88%
2023 S$38.76 B-2.31%
2022 S$39.67 B-5.19%
2021 S$41.84 B4.82%
2020 S$39.92 B-0.31%
2019 S$40.04 B81.53%
2018 S$22.05 B3.7%
2017 S$21.27 B-8.19%
2016 S$23.16 B7.99%
2015 S$21.45 B0.84%
2014 S$21.27 B0.7%
2013 S$21.12 B-10.27%
2012 S$23.54 B-1.78%
2011 S$23.97 B13.34%
2010 S$21.15 B-2.94%
2009 S$21.79 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$117.67 B 199.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$71.79 B 82.57%๐Ÿ‡ซ๐Ÿ‡ท France
S$74.66 B 89.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$67.00 B 70.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$3.08 B-92.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.64 B-88.18%๐Ÿ‡ฎ๐Ÿ‡ณ India
S$43.65 B 11.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$54.01 B 37.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$83.83 B 113.19%๐Ÿ‡บ๐Ÿ‡ธ USA